OK Biotech Co., Ltd.

TWSE:4155 Voorraadrapport

Marktkapitalisatie: NT$3.3b

OK Biotech Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

OK Biotech heeft een totaal eigen vermogen van NT$2.5B en een totale schuld van NT$498.2M, wat de schuld-eigenvermogensverhouding op 20.3% brengt. De totale activa en totale passiva bedragen respectievelijk NT$3.4B en NT$973.4M. De EBIT OK Biotech is NT$9.2M waardoor de rentedekking -9.7 is. Het heeft contanten en kortetermijnbeleggingen van NT$192.8M.

Belangrijke informatie

20.3%

Verhouding schuld/eigen vermogen

NT$498.25m

Schuld

Rente dekkingsratio-9.7x
ContantNT$192.84m
AandelenNT$2.46b
Totaal verplichtingenNT$973.44m
Totaal activaNT$3.43b

Recente financiële gezondheidsupdates

OK Biotech (TPE:4155) Has A Pretty Healthy Balance Sheet

Mar 17
OK Biotech (TPE:4155) Has A Pretty Healthy Balance Sheet

Here's Why OK Biotech (TPE:4155) Can Manage Its Debt Responsibly

Dec 08
Here's Why OK Biotech (TPE:4155) Can Manage Its Debt Responsibly

Recent updates

OK Biotech's (TWSE:4155) Shareholders Have More To Worry About Than Lackluster Earnings

Aug 20
OK Biotech's (TWSE:4155) Shareholders Have More To Worry About Than Lackluster Earnings

OK Biotech Co., Ltd. (TPE:4155) Investors Should Think About This Before Buying It For Its Dividend

Apr 26
OK Biotech Co., Ltd. (TPE:4155) Investors Should Think About This Before Buying It For Its Dividend

Calculating The Fair Value Of OK Biotech Co., Ltd. (TPE:4155)

Apr 04
Calculating The Fair Value Of OK Biotech Co., Ltd. (TPE:4155)

OK Biotech (TPE:4155) Has A Pretty Healthy Balance Sheet

Mar 17
OK Biotech (TPE:4155) Has A Pretty Healthy Balance Sheet

Has OK Biotech (TPE:4155) Got What It Takes To Become A Multi-Bagger?

Mar 01
Has OK Biotech (TPE:4155) Got What It Takes To Become A Multi-Bagger?

Is OK Biotech Co., Ltd.'s (TPE:4155) Recent Price Movement Underpinned By Its Weak Fundamentals?

Feb 15
Is OK Biotech Co., Ltd.'s (TPE:4155) Recent Price Movement Underpinned By Its Weak Fundamentals?

A Look At OK Biotech's (TPE:4155) Share Price Returns

Jan 31
A Look At OK Biotech's (TPE:4155) Share Price Returns

We Wouldn't Rely On OK Biotech's (TPE:4155) Statutory Earnings As A Guide

Jan 17
We Wouldn't Rely On OK Biotech's (TPE:4155) Statutory Earnings As A Guide

Consider This Before Buying OK Biotech Co., Ltd. (TPE:4155) For The 5.4% Dividend

Jan 03
Consider This Before Buying OK Biotech Co., Ltd. (TPE:4155) For The 5.4% Dividend

Estimating The Intrinsic Value Of OK Biotech Co., Ltd. (TPE:4155)

Dec 21
Estimating The Intrinsic Value Of OK Biotech Co., Ltd. (TPE:4155)

Here's Why OK Biotech (TPE:4155) Can Manage Its Debt Responsibly

Dec 08
Here's Why OK Biotech (TPE:4155) Can Manage Its Debt Responsibly

Should You Be Impressed By OK Biotech's (TPE:4155) Returns on Capital?

Nov 23
Should You Be Impressed By OK Biotech's (TPE:4155) Returns on Capital?

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( NT$1.3B ) 4155 } overtreffen de korte termijn passiva ( NT$707.7M ).

Langlopende schulden: De kortetermijnactiva 4155 ( NT$1.3B ) overtreffen de langetermijnschulden ( NT$265.7M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 12.4% ) 4155 wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van 4155 is de afgelopen 5 jaar gedaald van 42.1% naar 20.3%.

Schuldendekking: De schuld van 4155 wordt niet goed gedekt door de operationele kasstroom ( 14.6% ).

Rentedekking: 4155 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.

Balans

Ontdek gezonde bedrijven

7D

1Y

7D

1Y

7D

1Y